SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Ogier who wrote (207)5/1/1997 12:24:00 PM
From: dino   of 7041
 
Zonagen is slated to give a 20 minute segment to present the company's story to 500+ attendees at the annual Cruttenden Roth Healthcare conference. The goal is to capture the interest of some of the nations largest and most influential institutional investors and portfolio managers. The presentation will be followed by breakout sessions where investors will get face time with Zonagen management to discuss the company's products. A total of 72 emerging growth companies from the biomed/healthcare industry will be featured at the luncheon which is scheduled for May 19-20 in New York City.

Assuming positive phase III results within the next 14 days, this seems like great timing to discuss the company's future action plan with the top investors and analysts on Wall Street.

All good things come to those that wait...

Dino
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext